Coombs--negative immune hemolytic anemia

Area of Science:

• Hematology
• Immunology
• Internal Medicine

Background:

• Immune hemolytic anemia (IHA) is typically diagnosed using the antiglobulin test (Coombs test).
• Some patients present with clinical signs of IHA despite undetectable antibody levels on red blood cells via standard antiglobulin testing.
• This subgroup represents a diagnostic challenge within hemolytic anemias.

Purpose of the Study:

• To describe the clinical characteristics and management of patients with immune hemolytic anemia and low, undetectable levels of red blood cell-bound antibody.
• To explore the potential mechanisms underlying hemolytic anemia in the presence of minimal antibody coating.
• To evaluate the therapeutic response in this specific patient population.

Main Methods:

• Clinical case review and analysis.
• Immunological assessment of red blood cell-bound antibodies.
• Evaluation of treatment outcomes (steroid therapy, splenectomy).

Main Results:

• Patients exhibit clinical features similar to Coombs-positive warm autoimmune hemolytic anemia.
• The concentration of antibody on red blood cells is below the detection threshold of standard antiglobulin tests.
• The course of the hemolytic disease is variable, influenced by antibody properties and reticuloendothelial system sensitivity.

Conclusions:

• Hemolytic anemia can occur with very low concentrations of red blood cell-bound antibody, below standard detection limits.
• Antibody characteristics and reticuloendothelial system function are key factors in the pathogenesis.
• Steroid therapy and splenectomy are generally effective treatments when indicated for these patients.